Macular degeneration is a breakdown of the macula—the small area lining the inside back of the eye that allows us to see straight ahead. The macula is used for seeing fine details and is important for reading, writing, threading a needle, or driving. Macular degeneration can make any activity that involves fine detail difficult or impossible.
People with macular degeneration may notice rapid onset of symptoms, slight symptoms that progress gradually, or no symptoms at all. Physicians may decide to test for the disease based on family history and any symptoms the patient is experiencing. A thorough eye examination is performed in which the physician looks for abnormalities in the back of the eye, in a portion of the retina called the macula.
Shoreline Vision offers the latest treatments for patients with macular degeneration, including new injectable drug therapy. The goal of these treatments is to preserve current eyesight and prevent future vision loss.
Retinal detachment is a disorder of the eye in which the retina peels away from its underlying layer of support tissue. Initial detachment may be localized, but without rapid treatment the entire retina may detach, leading to vision loss and blindness. It is a medical emergency.
The retina is a thin layer of light-sensitive tissue on the back wall of the eye. The optical system of the eye focuses light on the retina much like light is focused on the film in a camera. The retina translates that focused image into neural impulses and sends them to the brain via the optic nerve. Occasionally, posterior vitreous detachment, injury or trauma to the eye or head may cause a small tear in the retina. The tear allows vitreous fluid to seep through it under the retina, and peel it away like a bubble in wallpaper.
A retinal detachment is commonly preceded by a posterior vitreous detachment which gives rise to these symptoms:
Although most posterior vitreous detachments do not progress to retinal detachments, those that do produce the following symptoms:
Shoreline Vision offers the latest treatments for patients with a detached retina including Cryotherapy (freezing), Scleral buckle, Pneumatic retinopathy, and Vitrectomy.
If you have any questions regarding the use of the amsler grid, please call the office at 231-739-9009.
Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. It is caused by changes in the blood vessels of the retina.
In some people with diabetic retinopathy, blood vessels may swell and leak fluid. In other people, abnormal new blood vessels grow on the surface of the retina. The retina is the light-sensitive tissue at the back of the eye. A healthy retina is necessary for good vision.
If you have diabetic retinopathy, at first you may not notice changes to your vision. But over time, diabetic retinopathy can get worse and cause vision loss. Diabetic retinopathy usually affects both eyes.
As new blood vessels form at the back of the eye as a part of proliferative diabetic retinopathy (PDR), they can bleed (hemorrhage) and blur vision. The first time this happens, it may not be very severe. In most cases, it will leave just a few specks of blood, or spots, floating in a person’s visual field, though the spots often go away after a few hours. These spots are often followed within a few days or weeks by a much greater leakage of blood, which blurs vision. In extreme cases, a person will only be able to tell light from dark in that eye. It may take the blood anywhere from a few days to months or even years to clear from the inside of the eye, and in some cases the blood will not clear. These types of large hemorrhages tend to happen more than once, often during sleep.
Shoreline Vision offers the latest treatments for patients with a Diabetic Retinopathy including panretinal photocoagulation, scatter laser treatment and vitrectomy.
Optical coherence tomography (OCT), is a novel, non-invasive, non-contact diagnostic modality that produces high resolution images of the retinal architecture.
In patients with choroidal neovascularization (CNV) OCT images can show the choroidal neovascular membrane adjacent to the retinal pigment epithelial (RPE) layer. The membrane usually appears as a highly reflective, multilayered area disrupting the RPE/choriocapillaris layer and the photoreceptor outer segments. The focal increase in retinal thickness, subretinal fluid, serous retinal detachment, and RPE detachment can be visualized with OCT.
Fluorescein Angiography is a diagnostic test that provides visualization of the retinal blood circulation. This test provides the ophthalmologist with information that can be obtained with no other testing modality.
Sodium fluorescein dye is injected into a vein in the arm or hand of the patient. As the dye travels through the circulatory system of the body, a retina camera with special filters in place is used to photograph the transit of the dye through the retinal circulation.
Shoreline Vision is delighted to partner with Retina Specialists of Michigan in the care of our patients. Dr. Thomas Aaberg, Dr. Nathan Pezda, and Dr. Scott Westhouse provide retina services to patients in our Muskegon office.